PDA Webinar: Regulatory Challenges, Perspectives, and Convergence to Progress ATMPs
Registration Options
Individual Registration
Group Registration
We’re proud to welcome Peter W. Marks, MD, PhD, Director, CBER, U.S. FDA, who is joining us for this final webinar in 2020 PDA Advanced Therapy Medicinal Products Month Webinar Series!
As more and more companies are transitioning into cell and gene manufacturing, it is imperative that regulatory requirements allow for an acceptable risk-based approach that can be applied across manufacturing sites.
This webinar will highlight global regulatory challenges, current regulatory thinking, and efforts that are being proposed and/or undertaken to promote convergence in global regulatory approaches for cell and gene therapy manufacturing.
In addition to the presentation by Dr. Marks, we will be hearing an industry perspective on lessons learned from an RMAT designation request.
Following the presentations, get your questions answered during a live 30-minute Q&A session with the speakers.
This webinar is presented as part of the 2020 PDA Advanced Therapy Medicinal Products Month.
Contact
Program Inquiries
Training Course Inquiries
Registration Customer Care
Standard Registration
Member Price
$200GovernmentMember Only
$200
Health AuthorityMember Only
$200
AcademicMember Only
$200
Non-Member
$200
Day 1
11:00 a.m. – 11:30 a.m. 11:30 a.m. – 12:00 p.m. 12:00 p.m. – 12:30 p.m. |
Become a Sponsor
Interested in becoming a sponsor? Learn about opportunities and benefits.
Request InformationBecome an Exhibitor
Interested in becoming an exhibitor? Learn about opportunities and benefits.
Request InformationPLEASE READ PDA is not affiliated or contracted with any outside hotel contracting company. If someone other than PDA or the PDA chosen hotel contacts you suggesting that they represent any PDA event, they do not. It is PDA's recommendation that you book your hotel directly through the official PDA chosen hotel that is listed on our web site.